Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
When our Publisher was doing CE programs to medical professionals, I remember he used to ask the question, “If there was a drug you could take once a day with no side effects that lowered your A1c, weight and blood pressure, how much would you be willing to pay?” Once …
Read More »From the Editor
March, 2022
Latest Articles
August, 2022
-
19 August
Gestational Diabetes: One-Step or Two-Step Screening
No specific approach is used currently but which one is better? Every year, 2% to 10% of pregnant women are diagnosed with gestational diabetes. Gestational diabetes is a type of diabetes that develops in pregnant women who did not have diabetes before they got pregnant. Some causes or risk factors …
Read More » -
12 August
Could Dapagliflozin Be Beneficial in The Treatment of Patients with Type 2 Diabetes and Multiple Risk Factors
What are the effects of prescribing sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and multiple risk factors? Type 2 diabetes (T2D) usually occurs with multiple risk factors and complications. When treating patients with T2D targeting several risk factors, especially in the early stages of the disease state, …
Read More » -
12 August
Researchers Identify Issues Facing Older Adults Living with Diabetes
The diabetic UK teams developed eight priority questions and recommendations to improve the quality of life and care of older diabetic patients. Older adults living with diabetes are on the rise, and geriatricians are constantly experiencing difficulties providing care for these patient populations. The challenges may stem from the fact …
Read More » -
5 August
Hormone Therapy: Does it Lead to Increased Incidence of Diabetes in Trans Men and Women?
Studies have found that there may be a connection between hormone therapy use and type 2 diabetes, putting transgender individuals at an increased risk. Transgender individuals commonly use hormone therapy to generate the person’s desired physical characteristics. In addition to transforming the individuals’ physical characteristics, hormone therapy can also alter …
Read More » -
5 August
Blaming the COVID-19 Pandemic for Weight Gain
The current COVID-19 Pandemic may be to blame for weight gain in patients at a higher risk of developing diabetes. The Healthier You: NHS Diabetes Prevention Program (NHS DPP) developed by the National Health Service (NHS) in 2016 was created to delay or avert the emergence of type 2 diabetes …
Read More »
More Articles
August, 2022
-
5 August
The Link Between Diabetes Risk and Polyunsaturated Fatty Acids
Higher consumption of linoleic acid and higher levels in the body may mitigate diabetes mellitus risk. The primary polyunsaturated fatty acid (PUFA) is linoleic acid (LA), an essential fatty acid that makes up 85 to 90% of PUFA dietary consumption in the US. PUFA’s are classified into n-9, n-6, and …
Read More »
July, 2022
-
23 July
Young Age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease
Young age at diagnosis or disease aggression which increases lifetime risk of CKD in type 2 patients with diabetes Type 2 Diabetes, once considered a disease that comes about at an older age, is now increasingly diagnosed in younger adults. The number of people between the ages of 20-39 years …
Read More » -
23 July
Postpartum Use of Metformin to Prevent Type 2 Diabetes Mellitus
Metformin is used as first-line therapy but can also be used prophylactically. Almost three-quarters of women who experience gestational diabetes mellitus (GDM) will eventually develop type 2 diabetes (T2DM) in their lifetime. According to Whelan et al., “GDM is one of the most common complications of pregnancy affecting 6-8% of …
Read More » -
23 July
Dialysis and Anti-diabetic Drugs
The association between anti-diabetic drug use and survival outcomes in patients on dialysis. Diabetic kidney disease that leads to end-stage renal disease (ESRD) and dialysis is common among patients with type 2 diabetes. However, the impact of anti-diabetic drugs on patients undergoing dialysis is rarely studied. Most patients with ESRD …
Read More » -
16 July
Finerenone improves cardiovascular outcomes in patients with Type 2 Diabetes and CKD
Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients. Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …
Read More » -
16 July
Diabetes: Better Relief for Ulcerated Feet On the Horizon
A new treatment is on its way providing superior results for the patients suffering from diabetic foot ulcers. Chronic diabetic foot ulcers (DFUs) account for around 80% of lower limb amputations, resulting in effective medical treatment and cost burdens. Currently, the treatment for DFUs concentrates mainly on local wound care, …
Read More » -
16 July
The Dangers of Undiagnosed Eating Disorders in Patients with Type 1 Diabetes
Patients with type 1 diabetes and eating disorders have a greater risk of diabetic ketoacidosis and all-cause mortality. Eating disorders are severe illnesses associated with abnormal eating patterns secondary to pre-occupations with body weight and body image. Some examples of eating disorders include anorexia nervosa, bulimia nervosa, and binge eating …
Read More » -
9 July
The Role of Pharmacists in Diabetes Education
Pharmacists in the community setting play a role in diabetes screening and management by providing direct patient care. With the constant increase in the prevalence of diabetes, education is vital in understanding how to control disease progression. Pharmacists play an essential role in disease management, assessing medication adherence, and educating …
Read More » -
9 July
Diabetic Foot Disease and Oedema
Patients with diabetes are likely to be affected by Diabetic foot ulcers (DFUs). This type of disease is popular and enfeeble, generating a surge of serious morbidity and mortality combined with worldwide socio-economic problems. The symptoms of this disease such as infection and inflammation raise surrounding oedema of the foot. …
Read More » -
9 July
Liraglutide’s Effects in Overweight and Obese Adults at High CV Risk
Liraglutide to positively effect decrease in visceral fat in overweight and obese patients without history of type 2 diabetes. Critical drivers of adverse cardiometabolic outcomes in obese patients are visceral and ectopic fat, which is wrapped around the abdominal organs in the body. This type of fat can lead to …
Read More »